NewAmsterdam Pharma Co N.V. Stock: price and insider trades · United States · SEC (Form 4)Track the NewAmsterdam Pharma Co N.V. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 9 September 2026 (Cession). Among the most active insiders: Kooij Louise Frederika. Every trade is openly available.
€763,264
12 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives92 Thresholds0 Prospectus0 Other0
Declarations 92 total
▼ Director · Executives · 4 Sept 2026
1,600 shares @ US$25.32 Ordinary Shares SEC:0001193125-26-386508:0
◆ Vice President, Controller · Executives · 1 Sept 2026
3,200 shares 0Ordinary Shares SEC:0001193125-26-381953:0
▼ Chief Accounting Officer · Executives · 20 Jul 2026
70,200 shares @ US$29.96 25.9% of flow Ordinary Shares SEC:0001193125-26-312387:2
▼ Chief Accounting Officer · Executives · 20 Jul 2026
31,885 shares @ US$31.05 12.2% of flow Ordinary Shares SEC:0001193125-26-312387:3
▼ Chief Accounting Officer · Executives · 20 Jul 2026
2,915 shares @ US$31.71 1.1% of flow Ordinary Shares SEC:0001193125-26-312387:4
◇ Chief Accounting Officer · Executives · 20 Jul 2026
25,000 shares @ US$11.90 3.7% of flow Ordinary Shares SEC:0001193125-26-312387:0
◇ Chief Accounting Officer · Executives · 20 Jul 2026
80,000 shares @ US$11.17 11.0% of flow Ordinary Shares SEC:0001193125-26-312387:1
◇ Chief Accounting Officer · Executives · 22 Jun 2026
25,000 shares Ordinary Shares SEC:0001193125-26-281062:0
◇ Chief Accounting Officer · Executives · 22 Jun 2026
15,000 shares Ordinary Shares SEC:0001193125-26-281062:1
▼ Chief Accounting Officer · Executives · 22 Jun 2026
39,700 shares Ordinary Shares SEC:0001193125-26-281062:2
▼ Chief Accounting Officer · Executives · 22 Jun 2026
300 shares Ordinary Shares SEC:0001193125-26-281062:3
▼ Director · Executives · 11 Mar 2026
44,173 shares @ US$30.41 59.0% of flow Ordinary Shares SEC:0001193125-26-104239:0
▼ Director · Executives · 6 Mar 2026
28,186 shares @ US$29.41 36.4% of flow Ordinary Shares SEC:0001193125-26-100798:0
◇ Chief Scientific Officer · Executives · 5 Mar 2026
104,467 shares Ordinary Shares SEC:0001193125-26-099073:0
◇ Chief Executive Officer · Executives · 2 Mar 2026
443,707 shares Ordinary Shares SEC:0001193125-26-085947:0
◇ Chief Executive Officer · Executives · 24 Feb 2026
64,708 shares Ordinary Shares SEC:0001193125-26-078718:0
▼ Chief Scientific Officer · Executives · 20 Feb 2026
14,692 shares @ US$35.00 26.4% of flow Ordinary Shares SEC:0001193125-26-067260:0
◇ Chief Accounting Officer · Executives · 27 Jan 2026
39,816 shares @ US$10.90 11.1% of flow Ordinary Shares SEC:0001193125-26-029526:0
◇ Chief Accounting Officer · Executives · 23 Jan 2026
38,172 shares @ US$10.90 10.8% of flow Ordinary Shares SEC:0001193125-26-025012:0
◇ Chief Financial Officer · Executives · 20 Jan 2026
60,216 shares @ US$9.26 46.1% of flow Ordinary Shares SEC:0001193125-26-019686:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009268:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009274:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009273:0
▼ Chief Executive Officer · Executives · 7 Jan 2026
11,582 shares Ordinary Shares SEC:0001193125-26-009272:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009271:0
25 of 92 declarations
Load more (67 remaining) 关于 NewAmsterdam Pharma Co N.V. NewAmsterdam Pharma Co N.V. 是一家生物制药公司,专注于开发代谢疾病的创新疗法。该公司在纳斯达克上市,股票代码为 NAMS。